Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMNJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $139,980
Award facts
- Contract value 100% obligated
- $139,979.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $139,979.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was not issued under any set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee, with no identified subcontractor relationships, and will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to military healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. Through this vehicle, DMS Pharmaceutical Group supplies an extensive portfolio including branded and generic prescription medications, biologics, vaccines, over-the-counter drugs, and specialized medical consumables to meet the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMNJ?
SPE2DU26FEMNJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DU26FEMNJ worth?
The government has obligated $139,980 on SPE2DU26FEMNJ.
Is contract SPE2DU26FEMNJ an order under another contract?
Yes. SPE2DU26FEMNJ is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNJ competed?
The extent of competition for SPE2DU26FEMNJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award